Product approvals in regenerative medicine and rare diseases are among the highlights in our recap of recent FDA regulatory ...

Donald Trump’s allies have raised over $200 million to fund his inauguration, political operations, and presidential library. Major corporate contributors like Pfizer, OpenAI, and Meta have pushed the ...

Regeneron Pharmaceuticals is a strong investment with robust growth potential, fueled by FDA approvals and resilient market ...

Pfizer (NYSE: PFE) stock investors are curious about the valuation and prospects for the healthcare company. Stock prices used were the afternoon prices of Jan. 1, 2025. The video was published on Jan ...

The U.S. continues to charge significantly higher prices for prescription drugs compared with similarly wealthy countries.

Aetna is taking legal action against Pfizer, Novartis, Teva Pharmaceuticals and others, saying the list of drugmakers ...

Another $50,000 from tobacco giant Altria last month brings money raised to expand the Republican Party of Kentucky ...

Several large drugmakers, including Pfizer, Bristol Myers Squibb and Sanofi, increased the list prices of their drugs this ...

This is old news, the FDA-spinned student research is late by over a year. Other independent scientists and labs had made this discovery.

The German drugmaker will pay the NIH $791.5 million, while the University of Pennsylvania will get up to $467 million ...

A third dose of COVID-19 vaccine is beneficial among older Medicare beneficiaries, regardless of prior medically attended COVID-19 diagnoses.

San Diego-based iBio has signed a backloaded agreement with its existing partner AstralBio for a preclinical anti-myostatin ...